
DOI . ORG {
}
Title[redir]:
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer | Gastric Cancer
Description:
Background Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Methods Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. Results A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Conclusions Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
Matching Content Categories {📚}
- Health & Fitness
- Insurance
- Science
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We don’t know how the website earns money.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {🔍}
patients, irinotecan, dose, treatment, monotherapy, months, study, cancer, group, chemotherapy, gastric, median, agc, survival, treated, article, pfs, initial, advanced, therapy, phase, table, rdi, secondline, efficacy, present, google, scholar, clinical, patient, versus, pubmed, iii, mgm, cas, studies, thirdline, performed, adverse, events, nivolumab, trial, medical, safety, paclitaxel, grade, japan, laterline, salvageline, platinum,
Topics {✒️}
capecitabine/cisplatin versus 5-fluorouracil/cisplatin gastro-oesophageal junction cancer gastro-esophageal junction cancer her2-positive advanced gastric tcog gi-0801/birip trial gastro-oesophageal junction adenocarcinoma advanced gastric cancer 3rd-/4th-line therapy pretreated gastric cancer high-initial dose group low-initial dose group bi-weekly administration regimen hirofumi ohmura advanced esophagogastric cancer phase iii trial metastatic gastric cancer jcho kyushu hospital rdi-high group estimated privacy choices/manage cookies related subjects fluorouracil versus combination phase iii study manageable toxicity profile cancer chemother pharmacol present cohort included estimated cancer incidence therapy-related toxicities anti-her2 therapy clinical research institute treatment-related deaths her2-positive agc patients anti-vegfr therapy salvage-line treatment suggested bi-weekly administration randomised controlled trial gastric cancer gastric cancer gastric cancer 21 prior combination chemotherapy article makiyama diffuse-type adenocarcinoma intestinal-type adenocarcinoma refractory oesophagogastric adenocarcinoma common terminology criteria author information authors japanese clinical practice advanced gastric cisplatin versus s-1 prospective clinical studies present study showed
Schema {🗺️}
WebPage:
mainEntity:
headline:Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
description:Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
datePublished:2017-08-10T00:00:00Z
dateModified:2017-08-10T00:00:00Z
pageStart:464
pageEnd:472
sameAs:https://doi.org/10.1007/s10120-017-0759-9
keywords:
Gastric cancer
Advanced
Chemotherapy
Irinotecan
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_Fig1_HTML.gif
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
type:Person
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
description:Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
datePublished:2017-08-10T00:00:00Z
dateModified:2017-08-10T00:00:00Z
pageStart:464
pageEnd:472
sameAs:https://doi.org/10.1007/s10120-017-0759-9
keywords:
Gastric cancer
Advanced
Chemotherapy
Irinotecan
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_Fig1_HTML.gif
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
type:Person
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
Organization:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
External Links {🔗}(228)
- What's the income generated by https://link.springer.com/privacystatement each month?
- What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10120-017-0759-9/#main?
- How much does https://link.springer.com pull in monthly?
- Learn how profitable https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s10120-017-0759-9 is on a monthly basis
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#eds-c-header-nav's total income per month
- Learn how profitable https://link.springer.com/journals/ is on a monthly basis
- How much cash flow does https://www.springernature.com/gp/authors have monthly?
- Financial intake of https://link.springernature.com/home/
- Get to know what's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/#eds-c-header-popup-search
- https://order.springer.com/public/cart income
- What's the financial gain of https://link.springer.com/article/10.1007/s10120-017-0759-9/?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/journal/10120 generate monthly?
- How much profit is https://link.springer.com/article/10.1007/s10120-017-0759-9/#citeas making per month?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/content/pdf/10.1007/s10120-017-0759-9.pdf pull in monthly?
- Learn how profitable https://link.springer.com/article/10.1007/s10120-017-0759-9/journal/10120/aims-and-scope is on a monthly basis
- How much income is https://www.editorialmanager.com/gcan earning monthly?
- How much money does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Akitaka-Makiyama-Aff1 generate?
- See how much https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff1 makes per month
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Kohei-Arimizu-Aff1
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Gen-Hirano-Aff1 bring in?
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Chinatsu-Makiyama-Aff1's financial summary
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Yuzo-Matsushita-Aff2 bring in?
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff2
- Get to know https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Tsuyoshi-Shirakawa-Aff3's earnings
- Check the income stats for https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff3
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Hirofumi-Ohmura-Aff4
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff4 income
- Income figures for https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Masato-Komoda-Aff4
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Keita-Uchino-Aff4 bring in each month?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Kyoko-Inadomi-Aff5 rake in every month?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff5 bring in each month?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Shuji-Arita-Aff6 rake in every month?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff6 make?
- How much money does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Hiroshi-Ariyama-Aff5 make?
- What's the financial gain of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Hitoshi-Kusaba-Aff5?
- Revenue of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Yudai-Shinohara-Aff7
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff7 income
- Financial intake of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Miyuki-Kuwayama-Aff7
- Profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Tatsuhiro-Kajitani-Aff7
- What's the financial outcome of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Hisanobu-Oda-Aff7-Aff8?
- How much cash flow does https://link.springer.com/article/10.1007/s10120-017-0759-9/#Aff8 have monthly?
- How much profit does https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Taito-Esaki-Aff7 make?
- Financial intake of https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Koichi-Akashi-Aff5
- Get to know https://link.springer.com/article/10.1007/s10120-017-0759-9/#auth-Eishi-Baba-Aff6's earnings
- What are the earnings of https://orcid.org/0000-0001-9428-6772?
- What is the monthly revenue of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/metrics?
- What's the income generated by https://link.springer.com/10.1007/s00280-016-3138-z?fromPaywallRec=false each month?
- How much profit is https://link.springer.com/10.1007/s10120-016-0670-9?fromPaywallRec=false making per month?
- How much profit does https://link.springer.com/10.1186/s12876-018-0772-4?fromPaywallRec=false generate?
- https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/cancer-therapy's total income per month
- How profitable is https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/chemotherapy?
- Profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/combination-drug-therapy
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/gastric-cancer
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/gastrointestinal-cancer
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/subjects/pharmacotherapy produce monthly?
- Get to know what's the income of https://beta.springernature.com/pre-submission?journalId=10120
- What's the monthly money flow for https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR1?
- Monthly income for https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR2
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR3's total income per month
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR4's total income per month
- https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR5's revenue stream
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR6 net monthly?
- What's the financial outcome of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR7?
- See how much https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR8 makes per month
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR9 bring in?
- Financial intake of https://link.springer.com/article/10.1007/s10120-017-0759-9/#ref-CR10
- Earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR11
- How much profit does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR12 generate?
- How much cash flow does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR13 have monthly?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR14 gross monthly?
- What's the monthly income of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR15?
- How much cash flow does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR16 have monthly?
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#Tab1 produce monthly?
- What's the monthly money flow for https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/tables/1?
- What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#Tab2?
- Get to know what's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/tables/2
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#Tab3 rake in every month?
- Get to know what's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#Fig1
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/tables/3 pull in monthly?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/figures/1 rake in every month?
- What's the income generated by https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#Tab4 each month?
- What is the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9/tables/4?
- Earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR9
- How much money does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR17 generate?
- Financial intake of https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR18
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/article/10.1007/s10120-017-0759-9#ref-CR19 produce monthly?
- How much revenue does http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx generate?
- How much money does https://link.springer.com/doi/10.1007/s10120-016-0622-4 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Japanese%20gastric%20cancer%20treatment%20guidelines%202014%20%28ver.4%29&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-016-0622-4&volume=20&pages=1-19&publication_year=2017&author=Association%2CJapanese%20Gastric%20Cancer pull in monthly?
- What's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BD1cXivVaqtb4%3D?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18282805 pull in monthly?
- How profitable is http://scholar.google.com/scholar_lookup?&title=S-1%20plus%20cisplatin%20versus%20S-1%20alone%20for%20first-line%20treatment%20of%20advanced%20gastric%20cancer%20%28SPIRITS%20trial%29%3A%20a%20phase%20III%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2808%2970035-4&volume=9&pages=215-221&publication_year=2008&author=Koizumi%2CW&author=Narahara%2CH&author=Hara%2CT&author=Takagane%2CA&author=Akiya%2CT&author=Takagi%2CM?
- What are the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtlGit7bI?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19818685 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Fluorouracil%20versus%20combination%20of%20irinotecan%20plus%20cisplatin%20versus%20S-1%20in%20metastatic%20gastric%20cancer%3A%20a%20randomised%20phase%203%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2809%2970259-1&volume=10&pages=1063-1069&publication_year=2009&author=Boku%2CN&author=Yamamoto%2CS&author=Fukuda%2CH&author=Shirao%2CK&author=Doi%2CT&author=Sawaki%2CA pull in monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19153121 makes per month
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Capecitabine%2Fcisplatin%20versus%205-fluorouracil%2Fcisplatin%20as%20first-line%20therapy%20in%20patients%20with%20advanced%20gastric%20cancer%3A%20a%20randomised%20phase%20III%20noninferiority%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn717&volume=20&pages=666-673&publication_year=2009&author=Kang%2CYK&author=Kang%2CWK&author=Shin%2CDB&author=Chen%2CJ&author=Xiong%2CJ&author=Wang%2CJ?
- Revenue of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BD1cXisFSktg%3D%3D
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18172173's earnings
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Capecitabine%20and%20oxaliplatin%20for%20advanced%20esophagogastric%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa073149&volume=358&pages=36-46&publication_year=2008&author=Cunningham%2CD&author=Starling%2CN&author=Rao%2CS&author=Iveson%2CT&author=Nicolson%2CM&author=Coxon%2CF bring in?
- What's the financial intake of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVymt7zO?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20728210 gross monthly?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Trastuzumab%20in%20combination%20with%20chemotherapy%20versus%20chemotherapy%20alone%20for%20treatment%20of%20HER2-positive%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20cancer%20%28ToGA%29%3A%20a%20phase%203%2C%20open-label%2C%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2810%2961121-X&volume=376&pages=687-697&publication_year=2010&author=Bang%2CYJ&author=Cutsem%2CE&author=Feyereislova%2CA&author=Chung%2CHC&author=Shen%2CL&author=Sawaki%2CA?
- https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC3MXht1Ohs7vK income
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21742485's total income per month
- http://scholar.google.com/scholar_lookup?&title=Survival%20advantage%20for%20irinotecan%20versus%20best%20supportive%20care%20as%20second-line%20chemotherapy%20in%20gastric%20cancer%E2%80%94a%20randomised%20phase%20III%20study%20of%20the%20Arbeitsgemeinschaft%20Internistische%20Onkologie%20%28AIO%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2011.06.002&volume=47&pages=2306-2314&publication_year=2011&author=Thuss-Patience%2CPC&author=Kretzschmar%2CA&author=Bichev%2CD&author=Deist%2CT&author=Hinke%2CA&author=Breithaupt%2CK's financial summary
- What's the financial outcome of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC38Xptlyrt7c%3D?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22412140 income
- How profitable is http://scholar.google.com/scholar_lookup?&title=Salvage%20chemotherapy%20for%20pretreated%20gastric%20cancer%3A%20a%20randomized%20phase%20III%20trial%20comparing%20chemotherapy%20plus%20best%20supportive%20care%20with%20best%20supportive%20care%20alone&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2011.39.4585&volume=30&pages=1513-1518&publication_year=2012&author=Kang%2CJH&author=Lee%2CSI&author=Lim%2CDH&author=Park%2CKW&author=Oh%2CSY&author=Kwon%2CHC?
- What's https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC3sXitVWjurjL's gross income?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24332238?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Docetaxel%20versus%20active%20symptom%20control%20for%20refractory%20oesophagogastric%20adenocarcinoma%20%28COUGAR-02%29%3A%20an%20open-label%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2813%2970549-7&volume=15&pages=78-86&publication_year=2014&author=Ford%2CHE&author=Marshall%2CA&author=Bridgewater%2CJA&author=Janowitz%2CT&author=Coxon%2CFY&author=Wadsley%2CJ
- What's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC3sXhsFOns77J?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24094768 bring in?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Ramucirumab%20monotherapy%20for%20previously%20treated%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20adenocarcinoma%20%28REGARD%29%3A%20an%20international%2C%20randomised%2C%20multicentre%2C%20placebo-controlled%2C%20phase%203%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2813%2961719-5&volume=383&pages=31-39&publication_year=2014&author=Fuchs%2CCS&author=Tomasek%2CJ&author=Yong%2CCJ&author=Dumitru%2CF&author=Passalacqua%2CR&author=Goswami%2CC each month?
- What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC2cXhs1SqurvJ?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25240821 generate?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Ramucirumab%20plus%20paclitaxel%20versus%20placebo%20plus%20paclitaxel%20in%20patients%20with%20previously%20treated%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20adenocarcinoma%20%28RAINBOW%29%3A%20a%20double-blind%2C%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2814%2970420-6&volume=15&pages=1224-1235&publication_year=2014&author=Wilke%2CH&author=Muro%2CK&author=Cutsem%2CE&author=Oh%2CSC&author=Bodoky%2CG&author=Shimada%2CY
- Explore the financials of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DyaK28XivFWqtbs%3D
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8633249?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=CPT-11%3A%20an%20original%20spectrum%20of%20clinical%20activity&journal=Semin%20Oncol&volume=23&pages=21-26&publication_year=1996&author=Rothenberg%2CML
- Earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC2cXjt1Sht7g%3D
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24190112?
- Get to know http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20open-label%2C%20phase%20III%20study%20comparing%20irinotecan%20with%20paclitaxel%20in%20patients%20with%20advanced%20gastric%20cancer%20without%20severe%20peritoneal%20metastasis%20after%20failure%20of%20prior%20combination%20chemotherapy%20using%20fluoropyrimidine%20plus%20platinum%3A%20WJOG%204007%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2012.48.5805&volume=31&pages=4438-4444&publication_year=2013&author=Hironaka%2CS&author=Ueda%2CS&author=Yasui%2CH&author=Nishina%2CT&author=Tsuda%2CM&author=Tsumura%2CT's earnings
- How much money does https://link.springer.com/doi/10.1007/s10120-011-0019-3 generate?
- How much profit does https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC3MXntFCkt7s%3D generate?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21340668
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Association%20of%20fluoropyrimidines%2C%20platinum%20agents%2C%20taxanes%2C%20and%20irinotecan%20in%20any%20line%20of%20chemotherapy%20with%20survival%20in%20patients%20with%20advanced%20gastric%20cancer&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-011-0019-3&volume=14&pages=155-160&publication_year=2011&author=Shitara%2CK&author=Matsuo%2CK&author=Mizota%2CA&author=Kondo%2CC&author=Nomura%2CM&author=Takahari%2CD
- How much money does https://link.springer.com/doi/10.1007/s00280-016-3138-z make?
- How much income is https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC28XhsVWks7%2FP earning monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27566700 makes per month
- How much income is http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20irinotecan%20monotherapy%20as%20third-line%20treatment%20for%20advanced%20gastric%20cancer&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-016-3138-z&volume=78&pages=809-814&publication_year=2016&author=Kawakami%2CT&author=Machida%2CN&author=Yasui%2CH&author=Kawahira%2CM&author=Kawai%2CS&author=Kito%2CY earning monthly?
- What's the income generated by https://link.springer.com/article/10.1007/s10120-017-0759-9/articles/cas-redirect/1:CAS:528:DC%2BC2cXivFCqsrw%3D each month?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24560487?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Biweekly%20irinotecan%20plus%20cisplatin%20versus%20irinotecan%20alone%20as%20second-line%20treatment%20for%20advanced%20gastric%20cancer%3A%20a%20randomised%20phase%20III%20trial%20%28TCOG%20GI-0801%2FBIRIP%20trial%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2014.01.020&volume=50&pages=1437-1445&publication_year=2014&author=Higuchi%2CK&author=Tanabe%2CS&author=Shimada%2CK&author=Hosaka%2CH&author=Sasaki%2CE&author=Nakayama%2CN
- Learn how profitable https://citation-needed.springer.com/v2/references/10.1007/s10120-017-0759-9?format=refman&flavour=references is on a monthly basis
- What's the profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Akitaka%20Makiyama?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akitaka%20Makiyama generate monthly?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akitaka%20Makiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Kohei%20Arimizu's financial summary
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kohei%20Arimizu
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kohei%20Arimizu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Gen%20Hirano's total income per month
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gen%20Hirano earns monthly
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gen%20Hirano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the monthly income of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Chinatsu%20Makiyama?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chinatsu%20Makiyama?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chinatsu%20Makiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What is the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Yuzo%20Matsushita?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuzo%20Matsushita?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuzo%20Matsushita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Tsuyoshi%20Shirakawa bring in?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tsuyoshi%20Shirakawa
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tsuyoshi%20Shirakawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the monthly income of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Hirofumi%20Ohmura?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hirofumi%20Ohmura
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hirofumi%20Ohmura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Masato%20Komoda rake in every month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masato%20Komoda rake in every month?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masato%20Komoda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Keita%20Uchino gross monthly?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Keita%20Uchino?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Keita%20Uchino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- What is the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Kyoko%20Inadomi?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kyoko%20Inadomi
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kyoko%20Inadomi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Shuji%20Arita make?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shuji%20Arita earning monthly?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shuji%20Arita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Hiroshi%20Ariyama generate?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroshi%20Ariyama
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroshi%20Ariyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Hitoshi%20Kusaba net monthly?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hitoshi%20Kusaba
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hitoshi%20Kusaba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Yudai%20Shinohara?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yudai%20Shinohara
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yudai%20Shinohara%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Miyuki%20Kuwayama rake in every month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Miyuki%20Kuwayama generate?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Miyuki%20Kuwayama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Learn about the earnings of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Tatsuhiro%20Kajitani
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tatsuhiro%20Kajitani generate?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tatsuhiro%20Kajitani%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Hisanobu%20Oda making per month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hisanobu%20Oda generate monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hisanobu%20Oda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much money does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Taito%20Esaki make?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Taito%20Esaki make?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Taito%20Esaki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- What's the profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Koichi%20Akashi?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koichi%20Akashi?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koichi%20Akashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much money does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?sortBy=newestFirst&dc.creator=Eishi%20Baba make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eishi%20Baba income
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eishi%20Baba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/mailto:[email protected] rake in every month?
- What's the financial intake of https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_MOESM1_ESM.docx?
- How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Irinotecan%20monotherapy%20as%20third-line%20or%20later%20treatment%20in%20advanced%20gastric%20cancer&author=Akitaka%20Makiyama%20et%20al&contentID=10.1007%2Fs10120-017-0759-9©right=The%20International%20Gastric%20Cancer%20Association%20and%20The%20Japanese%20Gastric%20Cancer%20Association&publication=1436-3291&publicationDate=2017-08-10&publisherName=SpringerNature&orderBeanReset=true generate?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s10120-017-0759-9 pull in?
- Monthly income for https://citation-needed.springer.com/v2/references/10.1007/s10120-017-0759-9?format=refman&flavour=citation
- What's the income of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?query=Gastric%20cancer&facet-discipline="Medicine%20%26%20Public%20Health"?
- What's the profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?query=Advanced&facet-discipline="Medicine%20%26%20Public%20Health"?
- Profit of https://link.springer.com/article/10.1007/s10120-017-0759-9/search?query=Chemotherapy&facet-discipline="Medicine%20%26%20Public%20Health"
- How much does https://link.springer.com/article/10.1007/s10120-017-0759-9/search?query=Irinotecan&facet-discipline="Medicine%20%26%20Public%20Health" bring in each month?
- How much revenue does https://link.springer.com/article/10.1007/s10120-017-0759-9/researchers/86128596SN bring in?
- How much money does https://link.springer.com/journals/a/1 generate?
- How much does https://link.springer.com/books/a/1 bring in each month?
- How much does https://link.springer.com/journals pull in?
- Learn how profitable https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral is on a monthly basis
- What's the profit of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much does https://www.springernature.com/gp/products make?
- What's the financial intake of https://www.springernature.com/gp/librarians?
- Explore the financials of https://www.springernature.com/gp/societies
- How much does https://www.springernature.com/gp/partners pull in?
- Check the income stats for https://www.springer.com/
- https://www.nature.com/ income
- Profit of https://www.biomedcentral.com/
- How much profit does https://www.palgrave.com/ make?
- How much does https://www.apress.com/ pull in?
- How much cash flow does https://link.springer.com/brands/discover have monthly?
- Learn how profitable https://www.springernature.com/gp/legal/ccpa is on a monthly basis
- What's the financial outcome of https://www.springernature.com/gp/info/accessibility?
- What are the earnings of https://link.springer.com/termsandconditions?
- How much does https://support.springernature.com/en/support/home pull in monthly?
- How much does https://link.springer.com/legal-notice pull in monthly?
- What's the financial outcome of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Check the income stats for https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref